NCT00069914View on ClinicalTrials.gov

Immune Response to Influenza Vaccine in HIV-Infected Individuals

CompletedOBSERVATIONAL
Enrollment

165

Participants

Timeline

Start Date

September 30, 2003

Study Completion Date

September 30, 2005

Conditions
HIV Infections
Trial Locations (1)

20892

National Institute of Allergy and Infectious Diseases (NIAID), Bethesda

All Listed Sponsors
lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT00069914 - Immune Response to Influenza Vaccine in HIV-Infected Individuals | Biotech Hunter | Biotech Hunter